Stock MSLP MUSCLEPHARM CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News MusclePharm Corporation

Equities

MSLP

US6273352012

Market Closed - OTC Markets
Other stock markets
 12:17:02 2024-07-01 pm EDT 		5-day change 1st Jan Change
0.000025 USD +2,400.00% Intraday chart for MusclePharm Corporation 0.00% +2,400.00%
2023 Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation CI
2023 FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q). CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation
CI
FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).
CI
Motion for Asset Sale Approved for MusclePharm Corporation
CI
FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.
CI
Stalking Horse Agreement Filed by MusclePharm Corporation
CI
Musclepharm Corporation Announces Resignation of Paul Karr as Director
CI
Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation
CI
First Amended Disclosure Statement Approved for MusclePharm Corporation
CI
Bidding Procedure Approved for MusclePharm Corporation
CI
Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer
CI
SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud
AQ
First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation
CI
Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation
CI
Motion for Asset Sale Filed by MusclePharm Corporation
CI
First Motion for Exclusivity Period Extension Approved For MusclePharm Corporation
CI
MusclePharm Corporation has withdrawn its IPO in the amount of $10 million.
CI
First Motion for Exclusivity Period Extension Filed by MusclePharm Corporation
CI
DIP Financing Approved for MusclePharm Corporation
CI
Amended DIP Financing Approved for MusclePharm Corporation
CI
Interim DIP Financing Approved for MusclePharm Corporation
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MSLP Stock
  4. News MusclePharm Corporation